Page 153 - CW E-Magazine (18-6-2024)

News from Abroad

GROWING PRESENCE
Vetter to expand capacity in US and Germany

Vetter, a German contract develop-
ment and manufacturing organisation
(CDMO), has announced plans to move
and expand its Development Services
site from Skokie, Illinois, to Des Plaines,
further investing in its US footprint.
Simultaneously, the company plans addi-
tional major investment in its commer-
cial business in the state of Saarland,
located in the Southwest of Germany are in need of even more capacity. We are cant growth of investments in research
bordering France and Luxembourg, to proud to announce further investments and production facilities in Germany by
complement its growth and capacity in Des Plaines, USA, and Germany,” he leading pharmaceutical companies. The
expansions in Ravensburg and Lange- added. The development plan involves Saarland government plans to develop a
nargen which are currently underway. a construction project at the Des Plaines technology park on the site in Saarlouis.
site and the relocation and expansion of Vetter has already started planning the
This adds more capacity for future Vetter Development Services US from phased development of a 125-acre site.
customers around the globe as the in- the Illinois Science and Technology Park
jectable industry is witnessing a rise in over the next years. New buildings for Pharmaceutical production at the site
outsourcing development, manufactur- clinical manufacturing and related ser- is expected to start by 2030 and Vetter is
ing, assembly and packaging needs to vices will be constructed. The move will planning to create up to 2,000 new local
CDMOs. “The approval of the Advisory effectively double the capacity of Vetter jobs in the years to come. In its ongoing
Board aligns with our commitment to Development Services in the US and commitment to serve customers and their
meet the long-term capacity needs of provide ample space for future expansion patients worldwide, Vetter is expanding
our clinical and commercial customers opportunities. its capacity for handling complex inject-
and their patients,” said the company’s ables. These expansions are part of the
Managing Director Mr. Peter Soelkner. Vetter said the board approval to exer- CDMO’s comprehensive, sustainable,
“We know that the multiannual-long in- cise an additional commercial produc- and long-term plan to position the com-
vestments at our Ravensburg and Lan- tion site in Saarlouis, Saarland, aligns pany for future growth in serving drug
genargen sites will contribute to this, with the recently approved ‘German product development, aseptic injectable
however the market and our customers Pharmaceutical Strategy’, and the signifi- filling, device assembly and packaging.
Sonneborn expands distribution partnership with IMCD

Sonneborn, a speciality chemicals novation in speciality
and ingredients brand belonging to US chemicals and ingre-
energy company, HF Sinclair, has an- dients,” he added.
nounced a strategic partnership with
IMCD, a Dutch distributor of speciality Under the terms of
chemicals. the agreement, IMCD
will act as a strategic
“We are delighted to expand our channel partner for Sonne
partnership with Sonneborn as it stra- born products in the
tegically covers several of our core seg- designated territories.
ments in Europe, the UK, Ireland, parts Sonneborn manufactures
of Africa, and India with a comple- high-purity speciality
mentary product portfolio,” informed distribution capabilities and Sonne- hydrocarbons for the personal care,
Mr. Marcus Jordan, Chief Operating born’s industry-leading products, this pharmaceutical, food, polymer, and
Officer at IMCD. “By leveraging IMCD’s partnership will drive growth and in- industrial markets.

Chemical Weekly June 18, 2024 153

Contents Index to Advertisers Index to Products Advertised